Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celgene Beats Zacks Estimate
Zacks
Saturday, January 30, 2010 - 10:48am
tags:
Celgene
Lilly’s Effient: Slow Start for a New Blood Thinner
WSJ Online
Friday, January 29, 2010 - 11:31am
tags:
blood thinners, Effient, Eli Lilly
Pfizer, Merck reps are tops to cardiologists
Fierce Pharma
Friday, January 29, 2010 - 11:28am
tags:
Merck, Pfizer, drug reps, sales reps, cardiologists
FDA seeks more data for Theravance drug
Yahoo/AP
Friday, January 29, 2010 - 11:20am
tags:
Theravance, FDA, Vibativ
Biogen Idec, Genzyme and the Struggles of Big Biotech
WSJ Online
Friday, January 29, 2010 - 11:18am
tags:
biotech, Biogen Idec, Genzyme
Gilead to repurchase up to $1 billion shares
Marketwatch
Friday, January 29, 2010 - 11:17am
tags:
stock buyback, Gilead Sciences
1-Star Stocks Poised to Plunge: Cytori Therapeutics?
Motley Fool
Friday, January 29, 2010 - 11:14am
tags:
Cytori
AstraZeneca Layoffs: Blame the Lawyers (and the Seroquel Marketers)
BNET Pharma
Friday, January 29, 2010 - 11:13am
tags:
Seroquel, layoffs, AstraZeneca
Keryx Biopharmaceuticals, AEterna Zentaris report positive perifosine study data
Yahoo/AP
Friday, January 29, 2010 - 11:00am
tags:
perifosine, Keryx, Aeterna Zentaris, cancer
Novartis chief warns states over cancelled vaccine orders
AFP/Google
Friday, January 29, 2010 - 9:49am
tags:
vaccines, Novartis, H1N1
Spectrum receives $16 million in payments
Yahoo/AP
Friday, January 29, 2010 - 9:47am
tags:
Spectrum Pharmaceuticals, Allergan
Amylin Misses Estimates
Yahoo/Zacks.com
Friday, January 29, 2010 - 9:39am
tags:
Amylin, earnings
Merck, Pfizer Overcharged New York for Medicines, Judge Rules
Bloomberg
Friday, January 29, 2010 - 8:47am
tags:
New York, Merck, Pfizer, Novartis, Mylan, Teva Pharmaceuticals, drug pricing, AWP
Bristol CEO ‘Out Hunting’ for Deal With $10 Billion
Bloomberg
Friday, January 29, 2010 - 8:46am
tags:
Bristol-Myers Squibb, Pharma CEOs, M&A, James Cornelius
Amgen Sees Put Buying
TheStreet.com
Thursday, January 28, 2010 - 9:28pm
tags:
Amgen
Health-Care Reform Is Dead. Probably.
Motley Fool
Thursday, January 28, 2010 - 9:16pm
tags:
healthcare reform, healthcare bill
The Biggest Development-Stage Drugmaker, Ever
Motley Fool
Thursday, January 28, 2010 - 6:49pm
tags:
Eli Lilly, pipelines
Blueprint for the next blockbuster drug
FT.com
Thursday, January 28, 2010 - 6:48pm
tags:
Merck, GSK, AstraZeneca, Pfizer
Only the Strong Survive at Pfizer
Motley Fool
Thursday, January 28, 2010 - 6:47pm
tags:
Pfizer, Wyeth, pipelines
Drug stocks diverge; AstraZeneca falls on forecast
Marketwatch
Thursday, January 28, 2010 - 11:02am
tags:
AstraZeneca, drug stocks

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.